Boehringer will leverage ExpressionEdits' Genetic Syntax Engine which generates optimized introns to increase protein expression.

ExpressionEdits' Genetic Syntax Engine platform is designed to enhance gene expression within gene therapies by restoring introns.

One in 10 Americans live with a rare disease, which often lacks effective treatments. Such is the case for PIGA-CDG, an ultra ...

A study led by USC Assistant Professor of Computer Science Ruishan Liu has uncovered how specific genetic mutations influence ...

Orchard Therapeutics has tasked Robin Kenselaar with accelerating growth of Lenmeldy, the world’s most expensive drug, ...

Adverum Biotechnologies Inc. (NASDAQ:ADVM) stock has reached a 52-week low, dipping to $3.95, with a market capitalization of just $83.2 million. According to InvestingPro analysis, the company faces ...

Robin Fields ProPublica is a nonprofit newsroom that investigates abuses of power. Sign up to receive our biggest stories as soon as they’re published. Vincent Gaynor remembers, almost to the minute, ...

Researchers from the Tata Memorial Centre (TMC), Mumbai, and the National Institute of Biomedical Genomics (NIBMG) in West Bengal on Wednesday claimed to have found key genomic factors that contribute ...

We recently compiled a list of the 10 Cheap Biotech Stocks to Invest in Now. In this article, we are going to take a look at ...